PubMed · 222600
Decrease of cyclic GMP in cerebellar cortex by intrastriatal (--)-sulpiride.
Abstract
Intraperitoneal administration of (--)-sulpiride (12 to 50 mg/kg) produced a dose-related decrease in cGMP content in cerebellar cortex, while the (+)-sulpiride (10 microgram), but not after intracerebellar injection. These findings support the contention that (--)-sulpiride modifies cerebellar cGMP levels through and action on striatal dopamine receptors.
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
M G Corda, M Casu, G Biggio. 1979-05-01. Decrease of cyclic GMP in cerebellar cortex by intrastriatal (--)-sulpiride.. https://doi.org/10.1016/0014-2999(79)90203-6
Cite the original work for its findings. Save a collection to share your selection of sources.